Eli Lilly and Novo Nordisk may lower price of obesity drugs as part of deal with the Trump administration
The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to consumers for as low as $149 per month, according to two people familiar with the negotiations.
(CNN, 2025-11-04T22:44:09Z)